In particular, section 1833(t)(16)(G) provides that with respect to a non-opioid treatment for pain relief furnished on or after January 1, 2025, ( and before January 1, 2028, the Secretary shall not package payment for the non-opioid treatment for pain relief into payment for a covered OPD service (or group of services) and shall make an additional payment for the non-opioid treatment for pain relief as specified in clause (ii) of that section
Could BPC-157 ever become FDA-approved
Its also ideal if you want the option to combine BPC-157 with TB-500 for a synergistic healing stack
Were talking quicker bounce-back from torn ligaments, muscle tears, joint inflammation, and post-surgery healing
Role of BPC-157 in preclinical studies BPC-157 , also known as Body Protection Compound-157, is the subject of numerous studies in cellular and animal models for its cytoprotective and regenerative activity
PMC12313605